Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. (September 2018)

Record Type:
Journal Article
Title:
Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. (September 2018)
Main Title:
Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy
Authors:
Kizy, S.
Altman, A.
Hui, J.Y.C.
Tuttle, T.
Marmor, S.
Lou, E.
Greeno, E.
Chang, K.
Denbo, J.W.
Jensen, E.
Abstract:
Is Part Of:
HPB. Volume 20(2018)Supplement 2
Journal:
HPB
Issue:
Volume 20(2018)Supplement 2
Issue Display:
Volume 20, Issue 2 (2018)
Year:
2018
Volume:
20
Issue:
2
Issue Sort Value:
2018-0020-0002-0000
Page Start:
S571
Page End:
Publication Date:
2018-09
Subjects:
Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:
https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1016/j.hpb.2018.06.2052 ↗
Languages:
English
ISSNs:
1365-182X
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
7764.xml